摘要
本文调整了FAM方案的剂量和用法,用于35例晚期腺癌的治疗,治疗后的总有效率为37.1％。以乳癌和胃癌疗效最佳,有效率分别为60％和47.4％,其次为肺癌16.7％,结、直肠癌基本无效。13例有效患者的中位生存期为15.1个月,其中乳癌和胃癌分别为19个月和11.5个月,故本方案显示有较好的疗效。
Thirty-five advanced adenocarcinomn were treated with F-A M ( 5-Fluorour acil, Adriamycin, Mi tomycin ) , which was a combination chemotherapy program. The cvcral response rale was 37.1%, in which mammary carcinoma and gastric carcinoma manifested beneficial effects, the response rate being 60% and 47.4% respectively. Next came lung-cancer accounting for 16.7%. The carcinoma of the crlon and rectum was associated with little effect.There were 13 responscr having a median survival of 15.1 months. The survival of mammary carcinoma and gastric carcinoma was 19 and 11.5 months, respectively. It has been shown that the adjusted chemotherapy program could produce a better curative effect
出处
《蚌埠医学院学报》
CAS
1989年第4期260-262,共3页
Journal of Bengbu Medical College
关键词
腺癌
5-氟脲嘧啶
阿霉素
adenocarcinoma
5-f luorouracial
adriamycin
mitomycin-C
therapeutic method
